Vaccinex, Inc.

NASDAQ:VCNX

3.29 (USD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Operating Activities:
Net Income -20.251-19.815-22.38-28.851-31.863-29.518-18.759-13.943
Depreciation & Amortization 0.1190.2070.1690.3070.2490.2230.2060.178
Deferred Income Tax 0.265-0.677-0.876-0.06501.91-3.743-9.31
Stock Based Compensation 0.4740.5450.5410.7320.4470.1770.3190.135
Change In Working Capital 0.318-0.011-3.21-1.0670.4961.624-0.6271.654
Accounts Receivables -0.786-0.1750.1570.741-0.26-0.522-0.013-0.085
Inventory 000002.023-0.3573.66
Accounts Payables 0.5210.457-2.1080.1220.7250.421-0.5550.407
Other Working Capital 0.583-0.293-1.259-1.930.031-0.2980.298-2.328
Other Non Cash Items 1.8410.6770.4580.297-0.0440.3081.2171.566
Operating Cash Flow -17.234-19.074-25.298-28.647-30.715-25.276-21.387-19.72
Investing Activities:
Investments In Property Plant And Equipment -0.067-0.099-0.032-0.29-0.078-0.235-0.068-0.793
Acquisitions Net 00000000
Purchases Of Investments 00000-20.75600
Sales Maturities Of Investments 000014.1516.7500
Other Investing Activites 000014.151-14.00600
Investing Cash Flow -0.067-0.099-0.032-0.2914.073-14.241-0.068-0.793
Financing Activities:
Debt Repayment -0.074-0.075-8.54-0.1080-5.5-6-0.8
Common Stock Issued 12.51917.0532.84828.47513.837.1257.99710.679
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 7.47417.05-0.9858.3913.89.3329.97417.157
Financing Cash Flow 12.44516.97523.32336.75713.840.95523.97416.357
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash -4.856-2.198-2.0077.82-2.8421.4382.519-4.156
Cash At End Of Period 1.5356.3918.58910.5962.7765.6184.181.661